Product: Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
Reason for recall: Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
Recall initiated: 20140505
Status: Terminated
Classification: Class I
Recall type: Voluntary: Firm initiated